AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Lexaria Bioscience Corp. Director's Dealing 2014

Jan 17, 2014

34983_dirs_2014-01-17_c5cd7e97-50f4-451a-bd99-a4132f714dc5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: LEXARIA CORP. (LXRP)
CIK: 0001348362
Period of Report: 2013-06-18

Reporting Person: BUNKA CHRISTOPHER (Director, Chairman, President & CEO, 10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares	1488561	Direct
Common Shares	3219586	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options	$0.2	2015-01-20	Common Shares (500000)	500000	Direct
Stock Options	$0.35	2016-07-11	Common Shares (200000)	200000	Direct
Stock Options	$0.1	2018-06-18	Common Shares (225000)	225000	Direct

Footnotes

F1: Restating total amount of Indirect Holdings as per 4A relating to misstated total of 30-Jul-08 which has carried through until this date. This figure, filed 18-Jun-13, was understated by 250 shares.

F2: C.A.B. Financial Services Ltd. is a private company wholly owned by C. Bunka.